Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

NCT01687673 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01687673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
October 5, 2012
Completion date
January 9, 2020
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma